# CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
> **ANDA200174** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2014-12-12
## Drug
- **FDA Application Number:** ANDA200174
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
- **Generic name:** CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE
- **Active ingredients:** BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
- **Dosage form:** OINTMENT
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** PADAGIS ISRAEL
- **Manufacturer:** Padagis Israel Pharmaceuticals Ltd
- **First approval:** 2014-12-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200174)
---
*MORVS · CC0 1.0*